News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Experimental Gastric Cancer Drug Enters Early Trial

Athenex and Eli Lilly and Company are conducting a phase 1b clinical trial for advanced gastric cancer on the combination of Oraxol plus Cyramza (ramucircumab, the VEGF receptor 2 antagonist). Oraxol is an oral version of the common chemo drug paclitaxel.

Read Source
X